RE:RE:About the addition of up to 9 CSS ...Hi wildbird1 - Yes, Theralase has so much research waiting in the wings. They just don't have the resources to take advantage of it.
GBM and NSCLC treatments using systemically delivered and X-ray activated Rutherrin should be next up. If systemic instillation and X-ray activation goes well, there is the potential for treating many other forms of cancer. Then there's all the melanoma and breast cancer research Dr. McFarland has been doing in recent years. And also her successes with low oxygen enviroment PSs which do not rely on ROS production. Plus, if all goes well, there's the covid vaccine phase 1 for 2024 and then other anti-viral and anti-bacterial treatments.
Theralase just needs the money to get the ball rolling.